AbbVie Makes Large Investment in Regenxbio's Gene Therapy for Retinal Diseases - Eyewire+
AbbVie on Twitter: "Tom Hudson, AbbVie Chief Scientific Officer How it started: How it's going: https://t.co/4o1roia3Yt" / Twitter
Major cash injection for Alphabet and AbbVie's R&D program
AbbVie Careers - Tom Hudson has six sisters, including a twin sister, who were all drawn to science careers. “There wasn't any pressure to be in this field,” Tom says. “My dad
Learn more about AbbVie, its West Coast R&D efforts in Oncology and its Corporate Ventures Arm - MBC BioLabs
Tom Hudson - PharmTech Focus
AbbVie developing COVID-19 therapy | Crain's Chicago Business
AbbVie on Twitter: "Tom Hudson joined AbbVie to help bring innovative treatments to patients faster. Learn more about his vision for the future of cancer treatment via @CancerResearch: https://t.co/XdfWDnDzpd https://t.co/QM87UDuA0j" / Twitter
Striving to Outsmart Cancer Together | AbbVie
A collaboration between the IRIC and AbbVie facilitated by IRICoR featuring Dr. Tom Hudson - YouTube
Our R&D Leaders - Our Science | AbbVie
Alpine Immune and AbbVie sign $865m immunology deal
AbbVie: ChemBeads, Improving Artificial Intelligence Through Human Ingenuity
Our R&D Leaders - Our Science | AbbVie
Thomas Hudson's email & phone | AbbVie's Senior Vice Research and Development and Chief Scientific Officer email
Partner Spotlight: Thomas Hudson - Cancer Research Institute (CRI)
AbbVie's drug shows improvement in psoriatic arthritis symptoms in trials
Discover and read the best of Twitter Threads about #FauciEmails
Dr. Thomas J. Hudson Net Worth (2022) | wallmine
AbbVie в Twitter: "Collaboration matters now more than ever. R&D leader Tom Hudson shared how the collective expertise of the scientific community will help us overcome #COVID19 and transform the future of
AbbVie on Twitter: "Tom Hudson, AbbVie Chief Scientific Officer How it started: How it's going: https://t.co/4o1roia3Yt" / Twitter
AbbVie's Skyrizi nabs psoriatic arthritis nod, its 2nd, shortly after Rinvoq | FiercePharma
AbbVie on Twitter: "Tom Hudson joined AbbVie to help bring innovative treatments to patients faster. Learn more about his vision for the future of cancer treatment via @CancerResearch: https://t.co/XdfWDnDzpd https://t.co/QM87UDuA0j" / Twitter
Eyeing its post-Humira future, AbbVie angles for broader Rinvoq use in U.S., Europe | FiercePharma
John Sansone - Sales Representative - AbbVie | LinkedIn
